Profil
Christen Baglaneas currently works as the Head of Investor Relations and Corporate Communications at Theseus Pharmaceuticals, Inc.
Postes actifs de Christen Baglaneas
Sociétés | Poste | Début |
---|---|---|
THESEUS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |